CD19CD20-CAR.p40-T

· Shenzhen University General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19CD20-CAR.p40-T, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma [Phase 1, Phase 2]